N Jaffe. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Age FactorsAlkylating Agents/therapeutic useAntibodies, Neoplasm/biosynthesisAntineoplastic Agents/therapeutic useChildCyclophosphamide/therapeutic useFemaleHumansImmunity, CellularMaleNeoplasms/pathologyNeuroblastoma/complicationsNeuroblastoma/drug therapyNeuroblastoma/etiologyNeuroblastoma/historyNeuroblastoma/immunologyNeuroblastoma/metabolismNeuroblastoma/mortalityNeuroblastoma/physiopathologyNeuroblastoma/radiotherapyNeuroblastoma/surgeryPrognosisSex FactorsTime FactorsVinca Alkaloids/therapeutic useVincristine/therapeutic use
Substances: See more » Alkylating AgentsAntibodies, NeoplasmAntineoplastic AgentsVinca AlkaloidsVincristineCyclophosphamide
Year: 1976 PMID: 782702 DOI: 10.1016/s0305-7372(76)80005-9
Source DB: PubMed Journal: Cancer Treat Rev ISSN: 0305-7372 Impact factor: 12.111